Skip to content
Slaton Case, MD

Inbox and Results

What the inbox contains

The electronic health record (EHR) inbox is where care continues between appointments. It contains test results, patient messages, medication requests, referral updates, forms, and work routed from colleagues.

For each item, answer four questions: What does it mean? How soon must someone act? Who will act? How will we know the action happened? Billing comes later.

ItemFirst questionPossible next step
Expected test resultDoes the whole result fit the anticipated plan?Communicate the interpretation and next monitoring step.
Unexpected or critical resultCould delay cause harm?Clinical assessment, direct contact, and appropriate urgent action.
New symptom messageDo I have enough information, and is asynchronous care safe?Remote evaluation, a call, a visit, or emergency care.
Refill requestDoes it meet the approved continuation pathway?Process within authorized instructions or route for clinical review.
Referral or future testIs it ordered, scheduled, completed, or still missing?Track the next step and remove barriers.

A critical value is a result flagged for urgent communication under the laboratory's policy. A red flag is a clinical feature suggesting a serious problem. They overlap, but are not identical: a clinically urgent problem may not trigger a laboratory callback.

What completion means

Define who owns follow-up in your practice. A workable default is the ordering clinician or covering team, until the task is completed or another recipient accepts it.

StageWhat is knownWhat remains
ReceivedThe result is available.Interpret it in context.
ReviewedA clinician or authorized pathway has interpreted it and determined an action.Communicate and arrange the plan.
Contact pendingA message or call was attempted.Confirm important communication; escalate if unsuccessful.
Follow-up pendingThe patient knows the plan, but a test, referral, or reassessment remains due.Track it to completion or a documented alternative decision.
CompletedThe necessary communication and action occurred, or an explicit alternative plan resolves the task.Retain any separate future surveillance task.

You can finish handling a message while a future care task remains open, provided that task is reliably tracked elsewhere.

The positive test and the unread message

A fecal immunochemical test (FIT), a stool screening test for colorectal cancer, is positive. You send a portal message and order colonoscopy. The message remains unread.

The result is reviewed, but communication and diagnostic follow-up are pending. Use an alternative contact method and retain a named tracking task.

A positive FIT requires colonoscopy to complete the screening evaluation. Explain that it is not itself a cancer diagnosis. Do not repeat FIT to decide whether the positive result can be disregarded.

ONC SAFER guide: test-result follow-up; USPSTF colorectal screening recommendation.

Close the message; keep the care task visible

Fictional workflow. After discussing a positive FIT, the patient agrees to colonoscopy but needs a participating facility. The ordering clinician creates a separate tracked task:

Finding: positive FIT; patient informed and understands the need for colonoscopy.
Next action: identify participating endoscopy service and confirm scheduling.
Tracking owner: referral coordinator, accepted today; follows scheduling, examination completion, and report receipt.
Clinical owner: ordering or designated covering clinician; reviews the report and communicates the plan.
Checkpoint: update clinician and patient by next Wednesday, sooner if access will miss the clinician’s requested timeframe.
Escalation: unresolved barrier returns to ordering clinician; coverage assigned during absence.
Completion: track examination and report, then clinician communicates the next plan.

The communication item may close after the handoff is accepted and this task is visible in the follow-up system. The colonoscopy task remains open. Next Wednesday is an example status checkpoint, not a recommended interval for completing every colonoscopy.

Decide urgency

A flagged number is the start of assessment. Review the patient's current symptoms, prior results, rate of change, relevant medications, and whether the sample is reliable. Then decide whether the patient needs emergency care, prompt outpatient reassessment, or routine follow-up.

PriorityResponseWhat to confirm
Possible immediate dangerAct when identified. Use direct contact and the emergency pathway.The patient or responder received the instructions; escalation occurred if contact failed.
Time-sensitive changeArrange clinical review within the interval the condition requires, often the same day.Symptoms, trend, medications, next test/visit, and who reviews it.
Nonurgent change in managementSet a specific, clinically appropriate review and communication deadline.The plan does not depend on an unscheduled “next visit.”
Expected result, plan unchangedUse the agreed routine communication pathway.The whole result fits the pathway and the patient gets an understandable plan.

A routine-results target, such as three working days, must have an explicit urgent-results exception. Set both pathways in the local protocol.

Potassium 5.8 mmol/L after a medication change

You receive an unexpected potassium of 5.8 after an ACE inhibitor was started. An angiotensin-converting enzyme inhibitor can increase potassium, but its presence does not establish the entire explanation.

Assess: contact the patient; ask about symptoms and acute illness; examine kidney-function trends and sample concerns; review all contributing drugs, supplements, and potassium-containing salt substitutes. Decide whether an ECG or urgent in-person assessment is needed. Then make a medication and repeat-testing plan appropriate to the findings.

A well patient with stable kidney function and reliable follow-up may be suitable for a short outpatient repeat interval. Acute kidney injury, weakness, or palpitations require more urgent assessment.

The UK Kidney Association recommends repeating an unexpected community potassium of 5.5–5.9 within three days, with escalation based on the clinical situation. This is a clinical reference, not a US laboratory callback policy. Base medication changes on that assessment; see monitoring after an ACE-inhibitor prescription.

UKKA hyperkalemia guideline; UKKA CKD management.

Interpret the whole result

Read every relevant component and compare it with the baseline and clinical question. Interpret positive and negative findings against the probability of disease before testing. A report can contain a normal answer to your original question and a separate finding that needs action.

The potassium is normal; creatinine has doubled

A basic metabolic panel shows normal potassium and creatinine 2.1 mg/dL, previously 1.0. “Potassium fine” does not address the report.

Determine the interval, current symptoms, urine output, volume status, recent illness, and medication exposures. Assess whether this represents an acute change and whether outpatient management is safe.

Document: the abnormality, relevant context, your disposition decision, any treatment changes, exact reassessment timing, and the clinician responsible for the repeat result.

A preliminary result is incomplete; a culture may still need organism identification or susceptibility results. An amended result changes a previously reported finding. Reassess a prior plan when an amendment matters, correct earlier patient advice when needed, and keep unresolved components tracked.

Incidental findings require interpretation too

An incidental finding was not the main reason for the test. It may still matter. Identify its type, size, location, comparison with prior studies, and recommended next step. Check whether the cited guideline actually applies before adopting an interval.

A small lung nodule

A 59-year-old never-smoker has a single solid 6 mm lung nodule incidentally found on CT. There is no known cancer or immunosuppression; the scan was not a lung-cancer screening examination.

This example fits the general population addressed by Fleischner guidance. A single solid 6–8 mm nodule generally has initial CT follow-up at 6–12 months; later follow-up depends on risk and appearance. Select and document the interval in context.

The scan found a small lung nodule. This is not a diagnosis of cancer, but follow-up is needed to check whether it changes. We agreed on a repeat CT in nine months. Our results coordinator will track scheduling, and I will review the report.

What if the patient has a known cancer, or the nodule is part-solid?

The same simple pathway should not be applied automatically. Confirm the appropriate clinical guidance or specialist plan. The nine-month example is not a universal rule for every 6 mm nodule.

Fleischner Society incidental pulmonary nodule guideline.

Communicate and confirm

A result message needs four parts: the result, what it means, what happens next, and when. Say who will act when the patient could otherwise assume the clinic is arranging something that is actually their responsibility.

An expected result with an unchanged plan

The patient's A1c is 7.1%. This is within their individualized goal, and treatment is stable.

Your A1c is 7.1%, within the goal we agreed on. Continue your current diabetes plan. Your next A1c is due in six months. Contact us sooner if your glucose readings or symptoms change.

It interprets the value against the patient's actual goal and states the next action. The same number in someone with a different goal or clinical course could require a different plan.

For important abnormalities, use a communication method suited to urgency, complexity, language needs, and the patient's ability to access it. A read receipt can show that a message was opened; it does not prove understanding. When a plan is consequential, ask the patient to explain the next step in their own words.

If contact fails, use a defined escalation process: verify contact information, try an alternative appropriate channel, involve authorized supports when appropriate, and seek urgent assistance if the situation requires it. Document attempts, the reason for escalation, and the person responsible for trying again. A letter is not an adequate emergency response.

When “we left a message” does not finish the task

  1. No response: the positive-FIT portal message remains unread and the first call is unanswered. Verify the contact details, document the attempt, and assign the next attempt through the office’s escalation process. Choose its timing from the clinical concern; this example is not a protocol for an emergency result.
  2. Contact reveals a barrier: the patient answers but cannot find a facility in network. Explain the result and confirm understanding, then send the accepted scheduling handoff above. Record what the office will do and when the patient will hear back.
  3. The patient declines after discussion: explore the reason, address misconceptions and access problems, and discuss consequences and alternatives. Document the informed decision and the agreed next contact or conditions for reconsideration. That is different from assuming refusal because messages went unanswered.

The number of contact attempts alone does not decide whether follow-up is complete. The clinician determines the response to remaining risk, and the task records that decision.

Patients may see results before you do

Federal information-blocking rules address interference with access to electronic health information. They do not themselves require every result to be proactively posted immediately, but routine delays solely to allow clinician review can be problematic. Applicable exceptions and circumstances matter. In practice, assume patients may see a result before you have explained it.

ONC access FAQ; ONC discussion of review-related delays.

Choose the right care setting

Asynchronous care means the patient and clinician communicate at different times, such as through portal messages. Synchronous care happens in real time by telephone, video, or in person. Choose the form of care from the problem and the information needed.

Remote prescribing requires enough information for a reliable assessment. Decide whether the available history, records, images, and home measurements are sufficient, whether examination or testing is needed, and whether delay between messages is safe.

SituationReasonable approach
Clarification of an existing planAnswer from the record if the question is clear and no new risk emerges.
Low-acuity problem adequately assessed remotelyRemote management may be appropriate, with a clear plan and reassessment instructions.
Missing essential history or examinationObtain the needed information or arrange a suitable visit. State the timeframe.
Possible emergencyMove immediately to direct contact and emergency action. Do not conduct a prolonged portal interview.

“Chest pressure now, sweating, and short of breath”

These symptoms warrant emergency action. Direct the patient to call 911 now and activate your team's urgent-contact process. Do not say “call 911 if worse” when the symptoms already suggest an emergency, or wait for an appointment response.

Document: when the message was identified, the information available, contact attempts and successful contact, instructions, and the escalation used. Confirm the communication rather than relying on a portal reply alone.

American Heart Association emergency warning signs.

For a spreading rash with fever, the issue is possible systemic illness and the need for assessment. A photo resembling eczema does not settle that question. Arrange timely evaluation and give specific emergency instructions for features such as breathing difficulty or severe allergic symptoms.

Build the team workflow

A protocol is a written set of eligibility criteria, actions, exclusions, and escalation instructions. It does not expand a staff member's legal scope. Separate medical assistants (MAs), registered nurses (RNs), and independently licensed clinicians; their roles are not interchangeable.

As a practical design, administrative staff can organize scheduling and contact information. Appropriately authorized staff can relay a clinician's interpretation and process tasks under approved instructions. RN triage and medication pathways require suitable training, scope, and protocols. Clinical interpretation and decisions outside a pathway go to the responsible clinician.

For example, the Medical Board of California states that MAs may not interpret or diagnose symptoms or test results. Check the rules in your jurisdiction and your institution's policies.

Make coverage explicit

Before an absence, designate who reviews new results, who handles urgent messages, how after-hours work reaches a clinician, and what happens to unfinished follow-up. A pooled inbox can work well if the schedule clearly identifies who is responsible for it.

A result routed to the wrong clinician

A potentially important result lands in your inbox, but you did not order the test.

Assess whether it needs immediate action. Identify the appropriate recipient and confirm acceptance of the handoff. If no recipient can be established, escalate through the practice's process while ensuring urgent care is addressed.

Document: the finding, urgency, recipient, acknowledgment, and any action already taken.

Track the work that has not arrived

A missing result may be more dangerous than an abnormal one that arrives. Maintain a way to identify overdue important tests, incomplete referrals, and promised repeat measurements. Ask whether the test was never scheduled, performed elsewhere, canceled, or completed without the report reaching you.

Sources: The Joint Commission's guidance on reliable result communication and the ONC SAFER guide.

Understand message billing

Message care may be included in another service, covered by a monthly arrangement, or separately billable. Determine which payment rules apply after deciding what care the patient needs.

Online digital E/M is evaluation and management through a qualifying online exchange. Codes 99421–99423 describe cumulative work by a physician or other qualified health care professional (QHP) over seven days. They require a patient-initiated service for an established patient, clinical decision-making, and the applicable time and related-visit exclusions. Routine result notification or an administrative refill request does not automatically qualify.

CodeCumulative eligible time2026 work / total RVUs
994215–10 minutes0.25 / 0.47
9942211–20 minutes0.50 / 0.92
9942321 minutes or more0.80 / 1.46

Check whether the message concerns the same or a related problem addressed at an E/M in the preceding seven days, and whether an in-person or telemedicine visit follows within the next seven days. Apply the related-visit exclusions before reporting the digital service separately. Check the payer's consent and patient-notification requirements, and explain applicable cost sharing.

A telephone or virtual check-in is a brief real-time discussion, often to decide whether a visit is needed. To report it separately, the medical discussion generally must last at least five minutes, must not originate from a related office visit or other E/M in the previous seven days, and must not lead to an E/M service or procedure within the next 24 hours or the soonest available appointment. Medicare uses 98016 for a 5–10 minute check-in with an established patient. A longer audio-only visit is a different service; Medicare typically reports it with the office E/M code and modifier 93 rather than a check-in code.

For a patient enrolled in advanced primary care management (APCM), online digital E/M and other specified communication services are included in the monthly bundle. Check whether another clinician is already billing overlapping management services.

AAFP digital E/M rules and cases; AAFP telehealth, audio-only, and virtual check-in coding; APCM overlap guidance; CMS April 2026 national non-facility RVUs.

Useful care that takes four minutes

An established patient asks a new, nonurgent clinical question. You have sufficient information to assess it and give appropriate advice in four minutes, with no further qualifying work during the seven-day period.

The work does not reach the five-minute threshold for 99421. Document the assessment and advice even though 99421 is not supported.

Recover and improve

If you discover a missed result, reassess the patient's current situation. Determine what must happen now, contact the patient in a manner appropriate to the finding and delay, and document the actual timeline. A late result may require a different plan from the one you would have made on its original date.

Record when the result became available, when it was recognized, the current assessment, action, communication, and follow-up. Do not backdate the review or hide the delay in a misleading addendum. Use your organization's patient-safety and disclosure processes when indicated.

Use drafts as drafts

Artificial intelligence tools can help prepare a response, but the signer must verify it against the actual report and chart. Check the patient, values, units, trend, interpretation, medication instructions, and next step. Review automated routing too: a missed urgency classification can hide the right message from the right person.

Measure follow-through, not just inbox volume

For a practice review, sample whether urgent items receive timely assessment, important messages reach patients, referrals complete, repeat tests return, and handoffs are accepted. Count overdue work and investigate recurring failure points.

Cases to work through

The patient has opened the positive-FIT message, but colonoscopy is not scheduled. Is the result complete?

The communication may be partly complete; diagnostic follow-up is not. Confirm understanding and barriers, keep a named tracking task, and help arrange colonoscopy. A read receipt and a referral order do not establish completed evaluation.

Two patients have potassium 5.8. One is well with stable kidney function; the other has weakness and a new creatinine rise. Use the same plan?

No. Symptoms, kidney function, trend, and reliability of follow-up change urgency. The second patient needs urgent clinical assessment rather than a routine message-and-repeat pathway. Verify each result and individualize medication decisions.

A nodule is 6 mm. What must you know before choosing its follow-up interval?

Whether it is solid or subsolid, solitary or multiple, its appearance and comparison, the patient's age and cancer risk, known malignancy or immunosuppression, and whether the examination was screening or incidental. Size alone is insufficient, and “not cancer” is not justified by the measurement.

An MA recognizes a result as “normal” and plans to send a reassuring interpretation. What should the pathway establish?

Who is authorized to interpret the result, which clinician-approved message may be relayed, and when to escalate. A protocol cannot authorize independent interpretation outside the MA's scope. Separate relaying an approved interpretation from making one.

Friday coverage ends with a nonurgent result still pending. What makes the handoff usable?

The finding, your assessment that it can safely wait, the intended next step, a specific review deadline, and a named recipient who accepts responsibility. Escalate if that handoff cannot be secured. Do not mark it completed simply to clear the coverage list.